SEI Investments

SEI Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

SEI Investments’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-146,020	Closed	-$210K	–	2502
2020 Q3	$210K	Hold	146,020	–	–	﹤0.01%	2226
2020 Q2	$291K	Buy	+146,020	New	+$286K	﹤0.01%	2099
2018 Q3	–	Sell	-73	Closed	-$1K	–	3036
2018 Q2	$1K	Sell	73 -117	-62%	-$1.2K	﹤0.01%	3483
2018 Q1	$1K	Buy	190 +145	+322%	+$1.34K	﹤0.01%	3335
2017 Q4	$0	Hold	45	–	–	﹤0.01%	3423
2017 Q3	$1K	Hold	45	–	–	﹤0.01%	3086
2017 Q2	$1K	Hold	45	–	–	﹤0.01%	2954
2017 Q1	$1K	Hold	45	–	–	﹤0.01%	2813
2016 Q4	$1K	Sell	45 -152	-77%	-$2.44K	﹤0.01%	2813
2016 Q3	$4K	Sell	197 -581	-75%	-$9.35K	﹤0.01%	2563
2016 Q2	$11K	Buy	778 +722	+1,289%	+$9.79K	﹤0.01%	2253
2016 Q1	$1K	Buy	+56	New	+$587	﹤0.01%	2435

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return